Allogeneic – Talk Bio

Actionable Insights Powered by AI

Wugen Nabs $115M for Pivotal Study of Allogeneic CAR-T

2 weeks ago talkbio0Tagged Allogeneic, CAR-T, Clinical Trials, fratricide-resistant, T-cell malignancies, Wugen

Wugen; CAR-T; allogeneic; off-the-shelf therapy; fratricide-resistant; funding; pivotal trial; T-cell malignancies

Tolerance Bio Secures $17.2M Seed Funding to Develop Thymus-Targeted Cell Therapies

11 months ago talkbio0Tagged Allogeneic, Bio, Cell Therapy, Drug Tolerance, immune-mediated diseases, Plant seeds, thymus extracts

Tolerance Bio, cell therapy, thymus, immune-mediated diseases, seed funding, allogeneic iPSC-based therapy